Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.19.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2019
Jun. 30, 2018
Current Assets    
Cash and cash equivalents $ 696,830 $ 430
Prepaid expenses and other current assets 39,624
Total Current Assets 736,454 430
Deferred offering costs 64,545
Deferred tax asset 1,222
Marketable securities held in Trust Account 70,881,151
Total Assets 71,618,827 64,975
Current liabilities    
Accounts payable and accrued expenses 234,592 1,000
Income taxes payable 136,419
Promissory note - related party 40,000
Total Current Liabilities 371,011 41,000
Promissory note - related party 500,000
Total Liabilities 871,011 41,000
Commitments
Common stock subject to possible redemption, 6,510,243 and no shares at redemption value as of June 30, 2019 and 2018, respectively 65,747,813
Stockholders' Equity    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value; 30,000,000 shares authorized; 2,239,757 and 2,012,500 shares issued and outstanding (excluding 6,510,243 and no shares subject to possible redemption) as of June 30, 2019 and 2018, respectively. [1] 224 201
Additional paid-in capital 4,653,397 24,799
Retained earnings/(Accumulated deficit) 346,382 (1,025)
Total Stockholders' Equity 5,000,003 23,975
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 71,618,827 $ 64,975
[1] Included an aggregate of 262,500 shares that were subject to forfeiture to the extent that the underwriters' over-allotment option was not exercised in full at June 30, 2018 (see Note 7).